From advancing quality and safety in blood, to supporting innovative research, and furthering the new frontier of biotherapies, AABB has not just kept pace with change in our field - we’ve driven it. As we look ahead, we want to ensure our name and brand reflects where we’ve been and where we’re going.
Our new name respects and connects our past, present and future: Association for the Advancement of Blood & Biotherapies.
The new logo symbolizes forward and collaborative thinking with a repetition of circular shapes that draw the eye across, around, in and out. The interlocking letters represent the connections of our community. Donor to Patient. Lab to Bedside. Member to Member.
Dana Devine, PhD
AABB President
David R. Green, MSA
AABB Past President
Debra S. BenAvram, FASAE, CAE
AABB Chief Executive Officer
Our brand reinforces AABB’s status as a leader in the blood and biotherapies field - and reflects the strength of our diverse membership - in more than 80 countries worldwide. The strength of our association is based on our community, which advances every aspect of the field. Together we challenge, support and celebrate each other in a place uniquely ours.
AABB’s new branding is the direct result of YOUR (our members) shared insights, perspectives, and experiences.
This feedback allowed us to define the future of AABB as the Association for the Advancement of Blood & Biotherapies.
Take a moment to comment on our new name and brand.
Keep in mind, there is much more is to come in 2022!
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
Email Signature
Social Media Post